$MCIG Announces New Date for Conference Call

• MCIG’s record financial growth numbers
• Recent developments in MCIG’s cost basis investments; to include, Vapolution, VitaCBD, Omni Health (OTC PINK: OMHE,) Agri-Contractors, and other strategic partnerships
• MCIG vision and plans for future expansion; to include, grow and production licensing and facility ownership, nationwide cannabis supply distribution, and our current research and development activities

MCIG management will answer investor questions submitted at info@mcig.org.

To participate by telephone, the domestic dial-in number is (712) 451-0011. The access code is 889964. Interested parties are asked to go to www.mcig.org and update their email and contact information so that they will receive a notification of the conference call 24 hours in advance of the call along with an outline of specific topics of discussions.

About mCig, Inc.

Headquartered in Henderson, Nevada, mCig Inc. (MCIG) A diversified company servicing the legal cannabis, hemp, and CBD markets via its lifestyle brands. MCIG has transitioned from a vaporizer manufacturer to industry leading large scale, full service cannabis cultivation construction company with its Grow Contractors division currently operating in the rapidly expanding Nevada market. The company looks forward to growing its core competencies to service the Ancillary legal Cannabis, Hemp, and CBD markets, with broader expansion to take place once federal laws change. For more information, visit www.mcig.org.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.

mCig, Inc.
Paul Rosenberg
Chief Executive Officer
info@mcig.org

SOURCE: mCig Inc.